Article
Small-molecule survivin inhibitor YM155 enhances radiosensitization in esophageal squamous cell carcinoma by the abrogation of G2 checkpoint and suppression of homologous recombination repair
19 Aug 2014
Abstract excerpt
BACKGROUND: Survivin is overexpressed in cancer cells and plays a crucial role in apoptosis evasion. YM155, a small-molecule inhibitor of survivin, could enhance the cytotoxicity of various DNA-damaging agents. Here, we evaluated the radiosensitizaion potential of YM155 in human esophageal squamous cell carcinoma (ESCC). METHODS: Cell viability was determined by CCK8 assay. The radiosensitization effect of YM155...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
